Kevin C. Tang, Chief Executive Officer, Chief Financial Officer, Officer, 10% Owner at Odonate Therapeutics, Inc. (ODT), bought 10,000 shares at $14.87 ($149K) on 2018-11-01, disclosed to the SEC on 2018-11-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ODT | BUY | 2020-12-23 | $8.4M | — | Filing → |
| LJPC | BUY | 2020-08-14 | $3.2M | — | Filing → |
| LJPC | BUY | 2020-02-03 | $1.7M | — | Filing → |